346 related articles for article (PubMed ID: 30478051)
61. Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.
Yao W; Oh YT; Deng J; Yue P; Deng L; Huang H; Zhou W; Sun SY
J Biol Chem; 2016 Oct; 291(41):21694-21702. PubMed ID: 27576686
[TBL] [Abstract][Full Text] [Related]
62. Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Bahram F; Hydbring P; Tronnersjö S; Zakaria SM; Frings O; Fahlén S; Nilsson H; Goodwin J; von der Lehr N; Su Y; Lüscher B; Castell A; Larsson LG
Oncotarget; 2016 Jan; 7(3):2837-54. PubMed ID: 26701207
[TBL] [Abstract][Full Text] [Related]
63. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.
Erhardt P; Schremser EJ; Cooper GM
Mol Cell Biol; 1999 Aug; 19(8):5308-15. PubMed ID: 10409722
[TBL] [Abstract][Full Text] [Related]
64. Increased expression of long noncoding RNA GAS6-AS2 promotes proliferation and inhibits apoptosis of melanoma cells via upregulating GAS6 expression.
Wen L; Zheng Y; Wen X; Zhang Y; Zeng W
IUBMB Life; 2019 Oct; 71(10):1503-1514. PubMed ID: 31162889
[TBL] [Abstract][Full Text] [Related]
65. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells.
Oh YT; Deng J; Yue P; Sun SY
Sci Rep; 2016 May; 6():26803. PubMed ID: 27222248
[TBL] [Abstract][Full Text] [Related]
66. N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.
Wang Z; Liu Y; Takahashi M; Van Hook K; Kampa-Schittenhelm KM; Sheppard BC; Sears RC; Stork PJ; Lopez CD
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):312-7. PubMed ID: 23248303
[TBL] [Abstract][Full Text] [Related]
67. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
68. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
[TBL] [Abstract][Full Text] [Related]
69. The evolutionarily conserved MAPK/Erk signaling promotes ancestral T-cell immunity in fish via c-Myc-mediated glycolysis.
Wei X; Zhang Y; Li C; Ai K; Li K; Li H; Yang J
J Biol Chem; 2020 Mar; 295(10):3000-3016. PubMed ID: 31996375
[TBL] [Abstract][Full Text] [Related]
70. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
Lents NH; Keenan SM; Bellone C; Baldassare JJ
J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
[TBL] [Abstract][Full Text] [Related]
71. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
72. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
73. The p53 transcriptional response across tumor types reveals core and senescence-specific signatures modulated by long noncoding RNAs.
Tesfaye E; Martinez-Terroba E; Bendor J; Winkler L; Olivero C; Chen K; Feldser DM; Zamudio JR; Dimitrova N
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326251
[TBL] [Abstract][Full Text] [Related]
74. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
75. Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-Raf.
Blair CM; Walsh NM; Littman BH; Marcoux FW; Baillie GS
BMC Cancer; 2019 Mar; 19(1):266. PubMed ID: 30909892
[TBL] [Abstract][Full Text] [Related]
76. Xanthoceraside induces apoptosis in melanoma cells through the activation of caspases and the suppression of the IGF-1R/Raf/MEK/ERK signaling pathway.
Jiao Q; Zou L; Liu P; Xu Q; Zhang Y; Yu Y; Zou L; Chi T; Ji X
J Med Food; 2014 Oct; 17(10):1070-8. PubMed ID: 25116791
[TBL] [Abstract][Full Text] [Related]
77. Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth.
Rudzka DA; Mason S; Neilson M; McGarry L; Kalna G; Hedley A; Blyth K; Olson MF
Small GTPases; 2021 Jul; 12(4):294-310. PubMed ID: 32569510
[TBL] [Abstract][Full Text] [Related]
78. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
[TBL] [Abstract][Full Text] [Related]
79. PCBP1 depletion promotes tumorigenesis through attenuation of p27
Shi H; Li H; Yuan R; Guan W; Zhang X; Zhang S; Zhang W; Tong F; Li L; Song Z; Wang C; Yang S; Wang H
J Exp Clin Cancer Res; 2018 Aug; 37(1):187. PubMed ID: 30086790
[TBL] [Abstract][Full Text] [Related]
80. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
Rommel C; Clarke BA; Zimmermann S; Nuñez L; Rossman R; Reid K; Moelling K; Yancopoulos GD; Glass DJ
Science; 1999 Nov; 286(5445):1738-41. PubMed ID: 10576741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
